Literature DB >> 17168772

Formulation of drugs in block copolymer micelles: drug loading and release.

J Liu1, H Lee, C Allen.   

Abstract

Block copolymer micelles have become accepted as a viable strategy for drug formulation and delivery. Block copolymer micelles may serve as solubilizers and/or true drug carriers depending on their drug retention properties in vivo. Indeed the formulation of hydrophobic drugs in these micelle systems has been shown to provide up to a 30,000 fold increase in the water solubility of some compounds. In addition, the administration of drugs in copolymer micelles has been shown to reduce their toxicity and improve their therapeutic efficacy. The present review is focused on the drug loading and release properties of block copolymer micelles. Specifically, the properties of the drug, properties of the micelle core and the presence of interactions between the drug and the core-forming block are discussed in terms of their influence on the drug loading and release properties of the micelles. The various methods employed to prepare drug-loaded micelles are reviewed and the in vitro release assays used to predict the in vivo release characteristics of the formulations are discussed. The balance between drug loading and micelle stability is highlighted as a critical factor in the optimization of micelle-based formulations. The in vivo performance of micelles as delivery systems is evaluated by comparing the pharmacokinetics of free drug and drug administered in micelle-based formulations. Overall, the composition-property and property-performance relationships outlined in this review may aid in guiding the rational design of block copolymer micelles for drug delivery. In addition, suggestions for future research in this area are provided as a means to assist in furthering block copolymer micelles as one of the leading advanced drug delivery technologies for the systemic administration of drugs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17168772     DOI: 10.2174/138161206779026263

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  31 in total

1.  Well-defined, size-tunable, multifunctional micelles for efficient paclitaxel delivery for cancer treatment.

Authors:  Juntao Luo; Kai Xiao; Yuanpei Li; Joyce S Lee; Lifang Shi; Yih-Horng Tan; Li Xing; R Holland Cheng; Gang-Yu Liu; Kit S Lam
Journal:  Bioconjug Chem       Date:  2010-07-21       Impact factor: 4.774

Review 2.  Imaging and drug delivery using theranostic nanoparticles.

Authors:  Siti M Janib; Ara S Moses; J Andrew MacKay
Journal:  Adv Drug Deliv Rev       Date:  2010-08-13       Impact factor: 15.470

3.  A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer.

Authors:  Kai Xiao; Juntao Luo; Wiley L Fowler; Yuanpei Li; Joyce S Lee; Li Xing; R Holland Cheng; Li Wang; Kit S Lam
Journal:  Biomaterials       Date:  2009-08-05       Impact factor: 12.479

4.  Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery.

Authors:  Yuanpei Li; Kai Xiao; Juntao Luo; Wenwu Xiao; Joyce S Lee; Abby M Gonik; Jason Kato; Tiffany A Dong; Kit S Lam
Journal:  Biomaterials       Date:  2011-06-11       Impact factor: 12.479

Review 5.  Photodynamic therapy: one step ahead with self-assembled nanoparticles.

Authors:  Pinar Avci; S Sibel Erdem; Michael R Hamblin
Journal:  J Biomed Nanotechnol       Date:  2014-09       Impact factor: 4.099

6.  Novel Nanomicellar Formulation Approaches for Anterior and Posterior Segment Ocular Drug Delivery.

Authors:  Kishore Cholkar; Ashaben Patel; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Recent Pat Nanomed       Date:  2012

7.  A novel size-tunable nanocarrier system for targeted anticancer drug delivery.

Authors:  Yuanpei Li; Kai Xiao; Juntao Luo; Joyce Lee; Shirong Pan; Kit S Lam
Journal:  J Control Release       Date:  2010-03-06       Impact factor: 9.776

8.  Effect of ultra-high pressure homogenization on the interaction between bovine casein micelles and ritonavir.

Authors:  M Corzo-Martínez; M Mohan; J Dunlap; F Harte
Journal:  Pharm Res       Date:  2014-10-01       Impact factor: 4.200

9.  Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease.

Authors:  Adam Smith; Brian Giunta; Paula C Bickford; Michael Fountain; Jun Tan; R Douglas Shytle
Journal:  Int J Pharm       Date:  2010-01-18       Impact factor: 5.875

10.  Polymeric curcumin nanoparticle pharmacokinetics and metabolism in bile duct cannulated rats.

Authors:  Peng Zou; Lawrence Helson; Anirban Maitra; Stephan T Stern; Scott E McNeil
Journal:  Mol Pharm       Date:  2013-04-22       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.